| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-06-29 21:15:30 UTC |
|---|
| Updated at | 2022-06-29 21:15:30 UTC |
|---|
| NP-MRD ID | NP0140232 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Magnesium Lithospermate B |
|---|
| Description | Magnesium lithospermate B, also known as magnesium lithospermic acid b or lithospermate b, belongs to the class of organic compounds known as 2-arylbenzofuran flavonoids. These are phenylpropanoids containing the 2-phenylbenzofuran moiety. Magnesium Lithospermate B was first documented in 2020 (PMID: 34321157). Based on a literature review a small amount of articles have been published on Magnesium lithospermate B (PMID: 35010979) (PMID: 34340903) (PMID: 34165232) (PMID: 33808650). |
|---|
| Structure | [Mg++].OC1=C2O[C@@H]([C@@H](C(=O)O[C@H](CC3=CC(O)=C(O)C=C3)C([O-])=O)C2=C(\C=C\C(=O)O[C@H](CC2=CC(O)=C(O)C=C2)C([O-])=O)C=C1)C1=CC(O)=C(O)C=C1 InChI=1S/C36H30O16.Mg/c37-20-6-1-16(11-24(20)41)13-27(34(45)46)50-29(44)10-5-18-3-9-23(40)33-30(18)31(32(52-33)19-4-8-22(39)26(43)15-19)36(49)51-28(35(47)48)14-17-2-7-21(38)25(42)12-17;/h1-12,15,27-28,31-32,37-43H,13-14H2,(H,45,46)(H,47,48);/q;+2/p-2/b10-5+;/t27-,28-,31+,32-;/m1./s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Magnesium lithospermic acid b | Generator | | Lithospermate b | MeSH |
|
|---|
| Chemical Formula | C36H28MgO16 |
|---|
| Average Mass | 740.9090 Da |
|---|
| Monoisotopic Mass | 740.12278 Da |
|---|
| IUPAC Name | Not Available |
|---|
| Traditional Name | Not Available |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [Mg++].OC1=C2O[C@@H]([C@@H](C(=O)O[C@H](CC3=CC(O)=C(O)C=C3)C([O-])=O)C2=C(\C=C\C(=O)O[C@H](CC2=CC(O)=C(O)C=C2)C([O-])=O)C=C1)C1=CC(O)=C(O)C=C1 |
|---|
| InChI Identifier | InChI=1S/C36H30O16.Mg/c37-20-6-1-16(11-24(20)41)13-27(34(45)46)50-29(44)10-5-18-3-9-23(40)33-30(18)31(32(52-33)19-4-8-22(39)26(43)15-19)36(49)51-28(35(47)48)14-17-2-7-21(38)25(42)12-17;/h1-12,15,27-28,31-32,37-43H,13-14H2,(H,45,46)(H,47,48);/q;+2/p-2/b10-5+;/t27-,28-,31+,32-;/m1./s1 |
|---|
| InChI Key | ANUBYMNVOPVATP-LKYMKJHQSA-L |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 2-arylbenzofuran flavonoids. These are phenylpropanoids containing the 2-phenylbenzofuran moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | 2-arylbenzofuran flavonoids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | 2-arylbenzofuran flavonoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - 2-arylbenzofuran flavonoid
- Tetracarboxylic acid or derivatives
- Cinnamic acid or derivatives
- Coumaric acid or derivatives
- Cinnamic acid ester
- 3-phenylpropanoic-acid
- Coumaran
- Catechol
- Styrene
- Alkyl aryl ether
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Fatty acid ester
- Phenol
- Fatty acyl
- Benzenoid
- Monocyclic benzene moiety
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Carboxylic acid ester
- Carboxylic acid salt
- Ether
- Oxacycle
- Carboxylic acid
- Organoheterocyclic compound
- Carboxylic acid derivative
- Organic oxide
- Hydrocarbon derivative
- Organic salt
- Carbonyl group
- Organooxygen compound
- Organic oxygen compound
- Organic cation
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Cheng TL, Lin ZY, Liao KY, Huang WC, Jhuo CF, Pan PH, Chen CJ, Kuan YH, Chen WY: Magnesium Lithospermate B Attenuates High-Fat Diet-Induced Muscle Atrophy in C57BL/6J Mice. Nutrients. 2021 Dec 27;14(1):104. doi: 10.3390/nu14010104. [PubMed:35010979 ]
- Tan OJ, Loo HL, Thiagarajah G, Palanisamy UD, Sundralingam U: Improving oral bioavailability of medicinal herbal compounds through lipid-based formulations - A Scoping Review. Phytomedicine. 2021 Sep;90:153651. doi: 10.1016/j.phymed.2021.153651. Epub 2021 Jul 17. [PubMed:34340903 ]
- Wang Y, Duo D, Yan Y, He R, Wu X: Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets. Biomed Pharmacother. 2020 Oct;130:110560. doi: 10.1016/j.biopha.2020.110560. Epub 2020 Aug 12. [PubMed:34321157 ]
- Huang WC, Liao KY, Hsieh SK, Pan PH, Kuan YH, Liao SL, Chen CJ, Chen WY: Magnesium lithospermate B supplementation improved prenatal Bisphenol A exposure-induced metabolic abnormalities in male offspring. Environ Toxicol. 2021 Sep;36(9):1932-1943. doi: 10.1002/tox.23313. Epub 2021 Jun 24. [PubMed:34165232 ]
- Luo X, Deng Q, Xue Y, Zhang T, Wu Z, Peng H, Xuan L, Pan G: Anti-Fibrosis Effects of Magnesium Lithospermate B in Experimental Pulmonary Fibrosis: By Inhibiting TGF-betaRI/Smad Signaling. Molecules. 2021 Mar 19;26(6):1715. doi: 10.3390/molecules26061715. [PubMed:33808650 ]
|
|---|